Connor, Clark & Lunn Investment Management (CC&L)’s Epizyme, Inc EPZM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-64,493	Closed	-$161K	–	1284
2021 Q4	$161K	Buy	+64,493	New	+$161K	﹤0.01%	1001
2015 Q2	–	Sell	-18,700	Closed	-$351K	–	679
2015 Q1	$351K	Sell	18,700 -14,700	-44%	-$276K	﹤0.01%	438
2014 Q4	$630K	Buy	+33,400	New	+$630K	0.01%	358